logo

For the Inventor, By the Inventor

Shanghai, China

Inventisbio Co., Ltd.

USPTO Granted Patents = 19



Forward Citations = 12

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Yueheng Jiang (15 out of 23 patents)

silverMedal Xing Dai (12 out of 41 patents)

bronzeMedal Yanqin Liu (9 out of 13 patents)

4.  Zixing Han (5 out of 5 patents)

5.  Zhenwu Wang (5 out of 5 patents)

6.  Liangshan Tao (5 out of 5 patents)

7.  Zhe Shi (5 out of 5 patents)

8.  Xing Dai (5 out of 6 patents)

9.  Yaolin Wang (3 out of 12 patents)

10.  Haotao Niu (3 out of 3 patents)

11.  Jifang Weng (3 out of 3 patents)

12.  Yaolin Wang (2 out of 17 patents)

13.  Yueheng Jiang (2 out of 2 patents)

14.  Xiaomei Wang (2 patents)


19 patents:

1. 12509448 - Salts of indoleamine 2,3-dioxygenase inhibitors (2025-12-30),
2. 12492184 - Heteroaryl compounds, preparation methods and uses thereof (2025-12-09),
3. 12427146 - C-terminal SRC kinase inhibitors (2025-09-30),
4. 12391677 - Thyroid hormone receptor agonists (2025-08-19),
5. 12246020 - Heterocyclic compounds, preparation methods and uses thereof (2025-03-11),
6. 12227491 - EGFR inhibitors (2025-02-18),
7. 12173010 - Heterocyclic compounds, preparation methods therefor, and methods of uses thereof (2024-12-24),
8. 12110289 - Heterocyclic compounds, preparation methods and uses thereof (2024-10-08),
9. 11903931 - Salts of selective estrogen receptor degraders (2024-02-20),
10. 11865115 - Heterocyclic compounds, preparation methods and uses thereof (2024-01-09),
11. 11691981 - Heterocyclic compounds, preparation methods therefor, and methods of uses thereof (2023-07-04),
12. 11685720 - Salt forms of URAT-1 inhibitors (2023-06-27),
13. 11639344 - EGFR inhibitors (2023-05-02),
14. 11498921 - Pyrimidine or pyridine compounds, preparation method therefor and pharmaceutical uses thereof (2022-11-15),
15. 11339127 - Salt forms of URAT-1 inhibitors (2022-05-24),
Company Overview
Inventisbio Co., Ltd. is a biotechnology firm based in Shanghai, specializing in the research and development of innovative therapeutic solutions. The company focuses on harnessing advanced biopharmaceutical technologies to address unmet medical needs, particularly in the fields of oncology and autoimmune diseases. With a commitment to scientific excellence, Inventisbio aims to translate cutting-edge research into effective treatments, contributing to the global healthcare landscape through its pioneering approaches and collaborative efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#153 in Shanghai

#1,553 in China

#32,693 in the World

Shanghai, CN
Shanghai, China

Inventisbio Co., Ltd.

Forward Citations = 12

13 inventors:

goldMedal Yueheng Jiang (15 out of 23 patents)

silverMedal Xing Dai (12 out of 41 patents)

bronzeMedal Yanqin Liu (9 out of 13 patents)

4.  Zixing Han (5 out of 5 patents)

5.  Zhenwu Wang (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Inventisbio Co., Ltd.. Retrieved from https://idiyas.com/company/inventisbio-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…